D-0141-2019 Class II Terminated

Recalled by Pharm D Solutions, LLC — Houston, TX

FDA drug recall D-0141-2019 was initiated by Pharm D Solutions, LLC on Sep 10, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 130 milliliters.

Recall Details

Product Type
Drugs
Report Date
Nov 7, 2018
Initiation Date
Sep 10, 2018
Termination Date
Feb 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
130 milliliters

Product Description

Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL), Pharm D Solutions, Houston, Texas --- NDC 69699-1323-05

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide

Code Information

Lots: 04112018:34 Discard by: 10/7/2018; 08012018:66 Discard by: 1/28/2019; 07262018:34 Discard by: 1/8/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0141-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.